By Amy Norton HealthDay Reporter THURSDAY, July 21, 2022 (HealthDay News) — Adding the drug Keytruda to standard chemotherapy can extend the lives of some women with an aggressive form of breast cancer, a new study finds. The study involved women with advanced triple-negative breast cancer, a hard-to-treat form of the disease. Keytruda (pembrolizumab) is …
Continue reading “Keytruda Extends Survival for Women With an Aggressive Breast Cancer”